Evidence map›Paper›PMID 33675807›Full record

ArticleExperimental cell research2021

Organotypic platform for studying cancer cell metastasis.

Giulia Spennati, Lisa F Horowitz, David J McGarry, Dominika A Rudzka, Garett Armstrong, Michael F Olson, Albert Folch, Huabing Yin

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Understanding Glioblastoma Dynamics Using 3D Organoids and Engineered Extracellular Matrix.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.Journal of experimental & clinical cancer research : CR · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Giulia SpennatiSchool of Engineering, University of Glasgow, Glasgow, UK; Department of Bioengineering, University of Washington, Seattle, WA, USA.
Lisa F HorowitzDepartment of Bioengineering, University of Washington, Seattle, WA, USA. Electronic address: lisafh@uw.edu.
David J McGarryDepartment of Chemistry and Biology, Ryerson University, Toronto, Ontario, Canada.
Dominika A RudzkaCancer Research UK Beatson Institute, Garscube Estate, Glasgow, UK.
Garett ArmstrongDepartment of Chemistry and Biology, Ryerson University, Toronto, Ontario, Canada.
Michael F OlsonDepartment of Chemistry and Biology, Ryerson University, Toronto, Ontario, Canada.
Albert FolchDepartment of Bioengineering, University of Washington, Seattle, WA, USA.
Huabing YinSchool of Engineering, University of Glasgow, Glasgow, UK. Electronic address: Huabing.yin@glasgow.ac.uk.
Toronto Metropolitan University · CAUniversity of Washington · USCancer Research UK Scotland Institute · GBRoyal College of Physicians and Surgeons of Glasgow · GB

Funding

Microfluidic Device to Profile Chemosensitivity in Glioma Slice CulturesR01CA181445 · NCI · UNIVERSITY OF WASHINGTON · PI FOLCH, ALBERT · 2014 to 2025
$5.3M
Cancer Research UK A10419Cancer Research UK A17196Cancer Research UK A18276CIHR PJT-169125NCI NIH HHS R01 CA181445
6 · The paper itself

Abstract

Metastasis is the leading cause of mortality in cancer patients. To migrate to distant sites, cancer cells would need to adapt their behaviour in response to different tissue environments. Thus, it is essential to study this process in models that can closely replicate the tumour microenvironment. Here, we evaluate the use of organotypic liver and brain slices to study cancer metastasis. Morphological and viability parameters of the slices were monitored daily over 3 days in culture to assess their stability as a realistic 3D tissue platform for in vitro metastatic assays. Using these slices, we evaluated the invasion of MDA-MB-231 breast cancer cells and of a subpopulation that was selected for increased motility. We show that the more aggressive invasion of the selected cells likely resulted not only from their lower stiffness, but also from their lower adhesion to the surrounding tissue. Different invasion patterns in the brain and liver slices were observed for both subpopulations. Cells migrated faster in the brain slices (with an amoeboid-like mode) compared to in the liver slices (where they migrated with mesenchymal or collective migration-like modes). Inhibition of the Ras/MAPK/ERK pathway increased cell stiffness and adhesion forces, which resulted in reduced invasiveness. These results illustrate the potential for organotypic tissue slices to more closely mimic in vivo conditions during cancer cell metastasis than most in vitro models.

Indexed as

BrainBreast NeoplasmsCell MovementCell ProliferationCell SurvivalFemaleGene Expression Regulation, NeoplasticHumansLiverMAP Kinase Signaling SystemMitogen-Activated Protein Kinase KinasesNeoplasm InvasivenessNeoplasm Metastasisras ProteinsTumor MicroenvironmentMitogen-Activated Protein Kinase Kinasesras Proteins3D microenvironmentAdhesionCell mechanicsMetastasisMigrationStiffness

Identifiers

PMID33675807
PMCPMC8806469
OpenAlexW3135282341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.